Nambia to India: Azithromycin Import Trade Route
India has recorded 1 verified shipments of Azithromycin imported from Nambia, representing a combined trade value of $1.5K USD. This corridor is served by 1 active Nambia exporters, with an average shipment value of $1.5K USD. The leading Nambia supplier is WINDHOEK MEDICAL SOLUTIONS (PTY) LTD , which accounts for 100% of total import value with 1 shipments worth $1.5K USD. On the buying side, ENCORE HEALTHCARE PRIVATE LIMITED is the largest Indian importer with $1.5K USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill of entry records. Values reported in FOB USD.
Route Intelligence Overview
The Nambia to India Azithromycin corridor is one of India's established pharmaceutical import routes from Nambia, with 1 shipments documented worth a combined $1.5K USD. The route is dominated by WINDHOEK MEDICAL SOLUTIONS (PTY) LTD , which alone accounts for roughly 100% of all import value, reflecting the consolidated nature of Nambia's azithromycin export sector.
Across 1 active Nambia suppliers, the average shipment value stands at $1.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 72% of all shipments, consistent with azithromycin's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 28 days port-to-port. The route has recorded an annual growth rate of 20.2%, placing it at rank #17 among India's top azithromycin import origins globally.
On the Indian buyer side, key Indian importers include ENCORE HEALTHCARE PRIVATE LIMITED . ENCORE HEALTHCARE PRIVATE LIMITED is the single largest Indian importer with 1 shipments valued at $1.5K USD.
Route Characteristics
- Average transit28 days
- Peak seasonQ2
- Primary modeSea freight
- Top port of entrySAHAR AIR CARGO ACC (INBOM4)
Market Position
- Global rank#17
- Annual growth+20.2%
- Demand growth+19.1%
- Regulatory ease74/100
Top 10 Azithromycin Exporters from Nambia to India
Showing top 10 of 1 Nambia suppliers exporting Azithromycin to India, ranked by total trade value (USD)
| Rank | Supplier (Nambia Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | WINDHOEK MEDICAL SOLUTIONS (PTY) LTD Avg $1.5K per shipment | 1 | $1.5K | 100.0% |
This table shows the top 10 of 1 Nambia companies exporting azithromycin to India, ranked by total trade value. The listed exporters are: WINDHOEK MEDICAL SOLUTIONS (PTY) LTD . WINDHOEK MEDICAL SOLUTIONS (PTY) LTD is the dominant supplier with 1 shipments worth $1.5K USD, giving it a 100% market share.
Top 10 Indian Azithromycin Importers from Nambia
Showing top 10 of 1 known Indian buyers receiving Azithromycin shipments from Nambia, ranked by import value
On the receiving end of this trade route, the leading Indian importers of Nambia azithromycin include ENCORE HEALTHCARE PRIVATE LIMITED . The largest importer is ENCORE HEALTHCARE PRIVATE LIMITED , accounting for $1.5K USD across 1 shipments — representing 100% of all azithromycin imports from Nambia on this route.
| Rank | Indian Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | ENCORE HEALTHCARE PRIVATE LIMITED | 1 | $1.5K | 100.0% |
Top 10 Azithromycin Formulations Imported from Nambia
Showing top 10 of 1 product formulations shipped on the Nambia to India Azithromycin route, ranked by trade value
India imports a wide range of azithromycin formulations from Nambia, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — ZITHROMAX TABLETS (AZITHROMYCIN 3 TALETS 500MG) ((TEST LIC.NO.TL/WZ/23/000300)SAMPLE FOR R & D PURPOSE (QTY 81 PAC) — accounts for $1.5K USD across 1 shipments. A total of 1 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | ZITHROMAX TABLETS (AZITHROMYCIN 3 TALETS 500MG) ((TEST LIC.NO.TL/WZ/23/000300)SAMPLE FOR R & D PURPOSE (QTY 81 PAC) | 1 | $1.5K | 100.0% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 72%, typical for bulk pharmaceutical shipments.
Top Indian Ports of Entry
SAHAR AIR CARGO ACC (INBOM4) handles the highest volume with 1 shipments. Transit time averages 28 days by sea.
Market Dynamics
India's azithromycin imports from Nambia are driven primarily by a handful of large-scale Nambia manufacturers. WINDHOEK MEDICAL SOLUTIONS (PTY) LTD with 1 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — Indian buyers benefit from Nambia supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — WINDHOEK MEDICAL SOLUTIONS (PTY) LTD — together account for 100% of total trade value on this route. The average shipment value of $1.5K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
On the buying side, ENCORE HEALTHCARE PRIVATE LIMITED is the largest importer with 1 shipments worth $1.5K USD — representing 100% of all azithromycin imports from Nambia on this route.
Route Statistics
- Trade Volume
- $1.5K
- Avg. Shipment
- $1.5K
- Suppliers
- 1
- Buyers
- 1
- Transit (Sea)
- ~28 days
- Annual Growth
- +20.2%
Related Analysis
Other Azithromycin Routes
Unlock the Full Nambia to India Azithromycin Dataset
TransData Nexus provides verified shipment-level records, exporter contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 1 shipments on this route.
Frequently Asked Questions — Nambia to India Azithromycin Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Nambia companies export Azithromycin to India?
The leading Nambia exporters of Azithromycin to India are WINDHOEK MEDICAL SOLUTIONS (PTY) LTD . WINDHOEK MEDICAL SOLUTIONS (PTY) LTD holds the largest market share at approximately 100% of total trade value on this route.
Q What is the total value of Azithromycin imports from Nambia to India?
India imports Azithromycin from Nambia worth approximately $1.5K USD across 1 recorded shipments. The average value per shipment is $1.5K USD.
Q Which Indian ports receive Azithromycin from Nambia?
The most active Indian port of entry is SAHAR AIR CARGO ACC (INBOM4) with 1 shipments. Nambia exporters primarily use sea freight for this route, with 72% of shipments going by sea and 20% by air.
Q How long does shipping take from Nambia to India for Azithromycin?
The average transit time for Azithromycin shipments from Nambia to India is approximately 28 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the Nambia to India Azithromycin import route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 20.2% with demand growth tracking at 19.1%. The route is ranked #17 among India's top Azithromycin import origins globally.
Q How many Nambia suppliers are active on this Azithromycin import route?
There are currently 1 active Nambia suppliers exporting Azithromycin to India. The market is moderately concentrated with WINDHOEK MEDICAL SOLUTIONS (PTY) LTD accounting for 100% of total shipment value.
Q Who are the main Indian importers of Azithromycin from Nambia?
The leading Indian importers of Azithromycin from Nambia include ENCORE HEALTHCARE PRIVATE LIMITED . ENCORE HEALTHCARE PRIVATE LIMITED is the largest buyer with 1 shipments worth $1.5K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Nambia export trade corridor identified from Indian Customs (DGFT) records for Azithromycin.
- 2.Supplier/Buyer Matching: 1 Indian exporters and 1 importers in Nambia matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 1 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1 Verified Shipments
1 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists